ADPROTECH
Adprotech is a biopharmaceutical company, develops pharmaceutical products for the treatment of organ transplant rejection, rheumatoid arthritis, bacterial infection, and stroke diseases. It develops and applies Prodaptin, a platform technology that increases the efficacy of therapeutics by targeting specific cells or tissues.
ADPROTECH
Industry:
Biotechnology Pharmaceutical
Address:
Saffron Walden, Essex, United Kingdom
Country:
United Kingdom
Status:
Active
Contact:
+44 87 0444 6144
Similar Organizations
MYR GmbH
MYR is a biotechnology company developing and commercilizing therapeutics for the treatment of chronic hepatitis B and D infections.
OrganoBalance GmbH
OrganoBalance GmbH develops, produces, and markets medicines used in the treatment of dental and skin bacterial infections.
Roche Diagnostics
Along with Roche Pharmaceuticals, Roche Diagnostics is an important part of the foundation that modern healthcare builds upon.
Vaxon Biotech
Vaxon Biotech is a company develops innovative therapeutic vaccines for the treatment of cancers, including lung, gastric, etc.
More informations about "Adprotech"
Adprotech 2025 Company Profile: Valuation, Investors ... - PitchBook
Information on acquisition, funding, investors, and executives for Adprotech. Use the PitchBook Platform to explore the full profile.See details»
Adprotech - Crunchbase Company Profile & Funding
Adprotech is a biopharmaceutical company, develops pharmaceutical products for the treatment of organ transplant rejection, rheumatoid arthritis, bacterial infection, and stroke diseases.See details»
AdProTech - Products, Competitors, Financials, Employees, …
About AdProTech Developer of adaptive protein technology to regulate immune responses in order to develop products which address serious illnesses including transplant rejection, …See details»
Adprotech Company Profile | Management and Employees List
Adprotech Profile and History APT is a supplier of high-quality plant-based proteins and starches for manufacturing in the UK and Europe. The company focuses on sustainability and …See details»
Synapse - Global Drug Intelligence Database - Patsnap
May 8, 2025 Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D …See details»
Adprotech - Overview, News & Competitors | ZoomInfo.com
AdproTech, based in Royston, U.K., was founded in 1997 and aims to be the leading company in advanced protein engineering for drug development. The drug development programme …See details»
ADPROTECH OÜ (17184470) - Overview - Inforegister.ee
ADPROTECH OÜ: Information technology and computer activities, Adlen Tolba | credit check, debts, contacts, paid taxes, employees, wages, finances, real estate, directorySee details»
Adprotech Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Adprotech Ltd including stock price, company news, executives, board members, and contact informationSee details»
adprotech.co.uk - APT | Advanced Protein Technology
With sustainability at the heart and technology at the forefront, our business model is revolutionary and will significantly enhance the supply chain credentials of all our customers providing them …See details»
Adprotech Being Acquired By Inflazyme In C$20M Deal
Last week, shareholders in privately held Adprotech Ltd. agreed to be taken over by Inflazyme Pharmaceuticals Ltd. for about C$20 million (US$14.9 million) in shares.See details»
Adprotech Ltd.:Company Profile & Technical Research,Competitor …
Adprotech Ltd. is a company that provides Transplant rejection, Medicine, Rheumatoid arthritis and more. Adprotech Ltd. is headquartered in United Kingdom Essex.See details»
Adprotech Ltd Company Profile, Financial and Strategic SWOT
DigitGaps report on Adprotech Ltd delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and company …See details»
Adprotech - Growth Outlook - Crunchbase
Adprotech is develops pharmaceutical products for the treatment of organ transplant rejection, rheumatoid arthritis, bacterial infection.See details»
Adprotech Being Acquired By Inflazyme In C$20M Deal
Apr 13, 2004 LONDON - Last week, shareholders in privately held Adprotech Ltd. agreed to be taken over by Inflazyme Pharmaceuticals Ltd. for about C$20 million (US$14.9 million) in …See details»
Adprotech - Tech Details - Crunchbase
Adprotech is develops pharmaceutical products for the treatment of organ transplant rejection, rheumatoid arthritis, bacterial infection.See details»
AdProTech Company Profile | Management and Employees List
AdProTech, LLC. is an industry leading new media company based in Englewood Cliffs, NJ. Since the dawn of the Internet and new wave marketing, the AdProTech Companies have been …See details»
Adprotech Ltd. - BioCentury Company Profiles - BCIQ
Aug 2, 2004 Adprotech Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
AdProTech CEO, Founder, Key Executive Team, Board of Directors …
Explore {AdProTech's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Adprotech - Crunchbase
Adprotech is develops pharmaceutical products for the treatment of organ transplant rejection, rheumatoid arthritis, bacterial infection.See details»
Adprotech - Profiles & Contacts - Crunchbase
Adprotech is develops pharmaceutical products for the treatment of organ transplant rejection, rheumatoid arthritis, bacterial infection.See details»